Molecular mechanism of Xuebijing in treating pyogenic liver abscess complicated with sepsis

doi:10.5847/wjem.j.1920-8642.2024.016

Abstract

Abstract:

BACKGROUND: Xuebijing (XBJ) can alleviate the inflammatory response, improve organ function, and shorten the intensive care unit (ICU) stay in patients with pyogenic liver abscess (PLA) complicated with sepsis, but the molecular mechanisms have not been elucidated. This study aimed to explore the molecular mechanism of XBJ in treating PLA complicated with sepsis using a network pharmacology approach.
METHODS: The active ingredients and targets of XBJ were retrieved from the ETCM database. Potential targets related to PLA and sepsis were retrieved from the GeneCards, PharmGKB, DisGeNet, Online Mendelian Inheritance in Man (OMIM), Therapeutic Targets Database (TTD), and DrugBank databases. The targets of PLA complicated with sepsis were mapped to the targets of XBJ to identify potential treatment targets. Protein-protein interaction networks were analyzed using the STRING database. Potential treatment targets were imported into the Metascape platform for Gene Ontology (GO) functional enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses. Molecular docking was performed to validate the interactions between active ingredients and core targets.
RESULTS: XBJ was found to have 54 potential treatment targets for PLA complicated with sepsis. Interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor (TNF) were identified as core targets. KEGG enrichment analysis revealed important pathways, including the interleukin-17 (IL-17) signaling pathway, the TNF signaling pathway, the nuclear factor-kappa B (NF-κB) signaling pathway, and the Toll-like receptor (TLR) signaling pathway. Molecular docking experiments indicated stable binding between XBJ active ingredients and core targets.
CONCLUSION: XBJ may exert therapeutic effects on PLA complicated with sepsis by modulating signaling pathways, such as the IL-17, TNF, NF-κB, and TLR pathways, and targeting IL-1β, IL-6, and TNF.

Key words: Xuebijing injection, Pyogenic liver abscess, Sepsis

Wei Zhou, Maiying Fan, Xiang Li, Fang Yu, En Zhou, Xiaotong Han. Molecular mechanism of Xuebijing in treating pyogenic liver abscess complicated with sepsis[J]. World Journal of Emergency Medicine, 2024, 15(1): 35-40.

Figures/Tables 4

Figure 1.

Figure 2.

Table 1.

Figure 3.

References 25

1	Li WF, Chen HJ, Wu S, Peng J. A comparison of pyogenic liver abscess in patients with or without diabetes: a retrospective study of 246 cases. BMC Gastroenterol. 2018; 18(1):144. doi: 10.1186/s12876-018-0875-y pmid: 30285638
2	Qi WQ, Huang CM, Bian F, Ge Q. Risk factors and early diagnosis of sepsis caused by liver abscess. Chin J Emerg Med. 2019; 28:1383-9.
3	Wei JX, Jiang HL, Chen XH. Endothelial cell metabolism in sepsis. World J Emerg Med. 2023; 14(1):10-6. doi: 10.5847/wjem.j.1920-8642.2023.019
4	Liu S, Yao C, Xie J, Liu H, Wang H, Lin Z, et al. Effect of an herbal-based injection on 28-day mortality in patients with sepsis: the EXIT-SEP randomized clinical trial. JAMA Intern Med. 2023; 183(7):647-55. doi: 10.1001/jamainternmed.2023.0780 pmid: 37126332
5	Meng X, Yang S, Cao Y, Zhao M. The clinical effect of Xuebijing on the patients with bacterial liver abscess and sepsis. Chin J Critical Care Med. 2019, 39(11):1050-2.
6	Li X, Wei SZ, Niu SQ, Ma X, Li HT, Jing MY, et al. Network pharmacology prediction and molecular docking-based strategy to explore the potential mechanism of Huanglian Jiedu Decoction against sepsis. Comput Biol Med. 2022; 144: 105389. doi: 10.1016/j.compbiomed.2022.105389
7	Liu JQ, Liu J, Tong XL, Peng WJ, Wei SS, Sun TL, et al. Network pharmacology prediction and molecular docking-based strategy to discover the potential pharmacological mechanism of Huai Hua San against ulcerative colitis. Drug Des Dev Ther. 2021; 15: 3255-76. doi: 10.2147/DDDT.S319786 pmid: 34349502
8	Zhou YY, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019; 10(1):1523. doi: 10.1038/s41467-019-09234-6 pmid: 30944313
9	Zhou W, Fan M, Tang Y, Guo H, Tan Z, Han X, et al. Effect of Xuebijing on inflammatory response and clinical efficacy in patients with sepsis. Int J Urol Nephrol. 2023; 43(1):97-100.
10	Zhao L, Chen F, Zhang YL, Yue L, Guo HR, Ye G, et al. Involvement of P450s and nuclear receptors in the hepatoprotective effect of quercetin on liver injury by bacterial lipopolysaccharide. Immunopharmacol Immunotoxicol. 2020; 42(3):211-20. doi: 10.1080/08923973.2020.1742154
11	Tang J, Diao P, Shu XH, Li L, Xiong LD. Quercetin and quercitrin attenuates the inflammatory response and oxidative stress in LPS-induced RAW264.7 cells: in vitro assessment and a theoretical model. Biomed Res Int. 2019; 2019:7039802.
12	Karimi A, Naeini F, Asghari Azar V, Hasanzadeh M, Ostadrahimi A, Niazkar HR, et al. A comprehensive systematic review of the therapeutic effects and mechanisms of action of quercetin in sepsis. Phytomedicine. 2021; 86:153567. doi: 10.1016/j.phymed.2021.153567
13	Zhang ZH, Yang HX, Jin Q, Wu YL, Cui ZY, Shang Y, et al.Luteolin attenuates hepatic injury in septic mice by regulating P2X7R-based HMGB1 release. Food Funct. 2021; 12(21): 10714-27. doi: 10.1039/D1FO01746B
14	Vajdi M, Karimi A, Karimi M, Abbasalizad Farhangi M, Askari G. Effects of luteolin on sepsis: a comprehensive systematic review. Phytomedicine. 2023; 113:154734. doi: 10.1016/j.phymed.2023.154734
15	Gao J, Yin J, Shen WJ, Shen W, Wang SY, Yao P. The effect of kaempferol on liver function injury in septic rats and its relationship with HIF-1α/HK2 signaling pathway. Chin J Crit Care Med. 2023; 43(4):279-84.
16	Zhu X, Wang XL, Ying TH, Li XL, Tang YD, Wang YF, et al. Kaempferol alleviates the inflammatory response and stabilizes the pulmonary vascular endothelial barrier in LPS-induced sepsis through regulating the SphK1/S1P signaling pathway. Chem Biol Interact. 2022; 368:110221. doi: 10.1016/j.cbi.2022.110221
17	Guo HL, Shi FD, Zhou Q, Liu QY, Wang YX, Song Y, et al. Interleukin-1β protection against experimental sepsis in mice. Inflammation. 2021; 44(1):358-70. doi: 10.1007/s10753-020-01341-7
18	Xiong SQ, Hong ZG, Huang LS, Tsukasaki Y, Nepal S, Di AK, et al. IL-1β suppression of VE-cadherin transcription underlies sepsis-induced inflammatory lung injury. J Clin Invest. 2020; 130(7):3684-98. doi: 10.1172/JCI136908 pmid: 32298238
19	Cao J, Liu WG, Li Y, Chen B, Yu TF, He ZB, et al. Value of IL-1β and IL-23 in predicting 28-day mortality due to sepsis: a retrospective study. Med Sci Monit. 2023; 29:e940163.
20	Roderburg C, Benz F, Schüller F, Pombeiro I, Hippe HJ, Frey N, et al. Serum levels of TNF receptor ligands are dysregulated in sepsis and predict mortality in critically ill patients. PLoS One. 2016; 11(4):e0153765. doi: 10.1371/journal.pone.0153765
21	Tiegs G, Horst AK. TNF in the liver: targeting a central player in inflammation. Semin Immunopathol. 2022; 44(4):445-59. doi: 10.1007/s00281-022-00910-2 pmid: 35122118
22	Guo Y, Chen L, Zheng Q, Chen J, Cai J, Cao H, et al. Effects of inhibition of IL-6/STAT3 signaling pathway on liver injury in septic rats. Chin J Trauma. 2011; 27(11):1049-52.
23	Hu P, Chen Y, Pang J, Chen X. Association between IL-6 polymorphisms and sepsis. Innate Immun. 2019; 25(8):465-72. doi: 10.1177/1753425919872818
24	Kumar V.Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets. Int Immunopharmacol. 2020; 89(Pt B):107087. doi: 10.1016/j.intimp.2020.107087
25	Yan BL, Chen F, Xu LJ, Xing JH, Wang XF. HMGB1-TLR4-IL23-IL17A axis promotes paraquat-induced acute lung injury by mediating neutrophil infiltration in mice. Sci Rep. 2017; 7:597. doi: 10.1038/s41598-017-00721-8 pmid: 28377603

[1]	Jingyi Wang, Li Weng, Jun Xu, Bin Du. Blood gas analysis as a surrogate for microhemodynamic monitoring in sepsis [J]. World Journal of Emergency Medicine, 2023, 14(6): 421-427.
[2]	Saifeng Chen, Xuewei Hao, Guo Chen, Guorong Liu, Xiaoyan Yuan, Peiling Shen, Dongfeng Guo. Effects of mesencephalic astrocyte-derived neurotrophic factor on sepsis-associated acute kidney injury [J]. World Journal of Emergency Medicine, 2023, 14(5): 386-392.
[3]	Mubing Qin, Yanxia Gao, Shigong Guo, Xin Lu, Qian Zhao, Zengzheng Ge, Huadong Zhu, Yi Li. Establishment and evaluation of animal models of sepsis-associated encephalopathy [J]. World Journal of Emergency Medicine, 2023, 14(5): 349-353.
[4]	Meng-meng An, Chen-xi Liu, Ping Gong. Effects of continuous renal replacement therapy on inflammation-related anemia, iron metabolism and prognosis in sepsis patients with acute kidney injury [J]. World Journal of Emergency Medicine, 2023, 14(3): 186-192.
[5]	Jue-xian Wei, Hui-lin Jiang, Xiao-hui Chen. Endothelial cell metabolism in sepsis [J]. World Journal of Emergency Medicine, 2023, 14(1): 10-16.
[6]	Hui Liu, Jie Hu, Jian-guo Xiao, Hong-jun Kang, Fei-hu Zhou. The procalcitonin-to-cortisol ratio is a potential prognostic predictor in sepsis with abdominal source: a retrospective observational study [J]. World Journal of Emergency Medicine, 2022, 13(6): 441-447.
[7]	Ralph Bou Chebl, Nadim Kattouf, Mohamad Assaf, Saadeddine Haidar, Gilbert Abou Dagher, Sarah Abdul Nabi, Rana Bachir, Mazen El Sayed. Comparing the demographic data and outcomes of septic shock patients presenting to teaching or non-teaching metropolitan hospitals in the United States [J]. World Journal of Emergency Medicine, 2022, 13(6): 433-440.
[8]	Shi-yuan Yu, Zeng-zheng Ge, Jun Xiang, Yan-xia Gao, Xin Lu, Joseph Harold Walline, Mu-bing Qin, Hua-dong Zhu, Yi Li. Is rosuvastatin protective against sepsis-associated encephalopathy? A secondary analysis of the SAILS trial [J]. World Journal of Emergency Medicine, 2022, 13(5): 367-372.
[9]	A-ling Tang, Mei-jia Shen, Guo-qiang Zhang. Intestinal microcirculation dysfunction in sepsis: pathophysiology, clinical monitoring, and therapeutic interventions [J]. World Journal of Emergency Medicine, 2022, 13(5): 343-348.
[10]	Xiao-kang Dai, Zhen-xing Ding, Yuan-yuan Tan, Hua-rui Bao, Dong-yao Wang, Hong Zhang. Neutrophils inhibit CD8⁺ T cells immune response by arginase-1 signaling in patients with sepsis [J]. World Journal of Emergency Medicine, 2022, 13(4): 266-273.
[11]	Xuan Fu, Xue Lin, Samuel Seery, Li-na Zhao, Hua-dong Zhu, Jun Xu, Xue-zhong Yu. Speckle-tracking echocardiography for detecting myocardial dysfunction in sepsis and septic shock patients: A single emergency department study [J]. World Journal of Emergency Medicine, 2022, 13(3): 175-181.
[12]	Mei-jia Shen, Li-chao Sun, Xiao-yu Liu, Meng-chen Xiong, Shan Li, A-ling Tang, Guo-qiang Zhang. Trichostatin A improves the inflammatory response and liver injury in septic mice through the FoxO3a/autophagy signaling pathway [J]. World Journal of Emergency Medicine, 2022, 13(3): 182-188.
[13]	Hai Hu, Jing-yuan Jiang, Ni Yao. Comparison of different versions of the quick sequential organ failure assessment for predicting in-hospital mortality of sepsis patients: A retrospective observational study [J]. World Journal of Emergency Medicine, 2022, 13(2): 114-119.
[14]	Li-wei Duan, Jin-long Qu, Jian Wan, Yong-hua Xu, Yi Shan, Li-xue Wu, Jin-hao Zheng, Wei-wei Jiang, Qi-tong Chen, Yan Zhu, Jian Zhou, Wen-bo Yu, Lei Pei, Xi Song, Wen-fang Li, Zhao-fen Lin. Effects of viral infection and microbial diversity on patients with sepsis: A retrospective study based on metagenomic next-generation sequencing [J]. World Journal of Emergency Medicine, 2021, 12(1): 29-35.
[15]	Hai-jiang Zhou, Tian-fei Lan, Shu-bin Guo. Outcome prediction value of National Early Warning Score in septic patients with community-acquired pneumonia in emergency department: A single-center retrospective cohort study [J]. World Journal of Emergency Medicine, 2020, 11(4): 206-215.